Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Phase 1
Completed
- Conditions
- Colon CancerLung CancerBreast Cancer
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Etubics Corporation
- Target Recruit Count
- 35
- Registration Number
- NCT01147965
- Locations
- 🇺🇸
Duke Cancer Research Institute, Duke University, Durham, North Carolina, United States
🇺🇸Medical Oncology Associates, PS, Spokane, Washington, United States
News
No news found